CareLit Fachartikel

Entrectinib in neurotrophic receptor tyrosine kinase fusion-positive (NTRK- fp) non-small cell lung cancer (NSCLC): integrated analysis of patients enrolled in STARTRK-2, STARTRK-…

L Paz-Ares, RC Doebel, AF Farago, S Liu, SP Chawla, D Tosi, CM Blakely, JC Krauss, D Sigal, L Bazhenova, T John, B Besse, J Wolf, T Seto, E Chow-Maneval, C Ye, B Simmons, GD Demetri · Pneumologie · 2020 · Heft S 01 S 01

Dokument
1214622
CareLit-ID
Jahr
2020
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Pneumologie
Autor:innen
L Paz-Ares, RC Doebel, AF Farago, S Liu, SP Chawla, D Tosi, CM Blakely, JC Krauss, D Sigal, L Bazhenova, T John, B Besse, J Wolf, T Seto, E Chow-Maneval, C Ye, B Simmons, GD Demetri
Ausgabe
Heft S 01 S 01 / 2020
Jahrgang 74
Seiten
–
Erschienen: 2020-03-01 00:00:00
ISSN
0934-8387
DOI
10.1055/s-0039-3403355

Zusammenfassung

Entrectinib in neurotrophic receptor tyrosine kinase fusion-positive (NTRK- fp) non-small cell lung cancer (NSCLC): integrated analysis of patients enrolled in STARTRK-2, STARTRK-1 and ALKA-372-001

Schlagworte

Entrectinib Neurotrophic Receptor Tyrosine Kinase Fusion-Positive Non-Small Cancer Nsclc Integrated Analysis Patients Pneumologie